标题
Current challenges for cancer vaccine adjuvant development
作者
关键词
-
出版物
Expert Review of Vaccines
Volume 17, Issue 3, Pages 207-215
出版商
Informa UK Limited
发表日期
2018-01-26
DOI
10.1080/14760584.2018.1434000
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- COX-2 inhibitor prevents tumor induced down regulation of classical DC lineage specific transcription factor Zbtb46 resulting in immunocompetent DC and decreased tumor burden
- (2017) Vipul K. Pandey et al. IMMUNOLOGY LETTERS
- Melanoma Sequentially Suppresses Different DC Subsets in the Sentinel Lymph Node, Affecting Disease Spread and Recurrence
- (2017) Mari F.C.M. van den Hout et al. Cancer Immunology Research
- Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
- (2017) Margherita Coccia et al. npj Vaccines
- TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes
- (2016) Paul F. McKay et al. PLoS One
- Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant
- (2016) Anna U. Bielinska et al. VACCINE
- Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment
- (2016) Fabian Flores-Borja et al. Journal of Immunology Research
- Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists
- (2015) Martin Kreutz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Microenvironment abnormalities and lymphomagenesis: Immunological aspects
- (2015) Joseph G. Taylor et al. SEMINARS IN CANCER BIOLOGY
- ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans
- (2015) Ka Yan Chung et al. VACCINE
- Cancer vaccines
- (2015) L. H. Butterfield BMJ-British Medical Journal
- Cancer vaccines
- (2015) L. H. Butterfield BMJ-British Medical Journal
- SA-4-1BBL and Monophosphoryl Lipid A Constitute an Efficacious Combination Adjuvant for Cancer Vaccines
- (2014) A. K. Srivastava et al. CANCER RESEARCH
- SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccines
- (2014) Rajesh K Sharma et al. Expert Review of Vaccines
- ISCOMATRIX Adjuvant Induces Efficient Cross-Presentation of Tumor Antigen by Dendritic Cells via Rapid Cytosolic Antigen Delivery and Processing via Tripeptidyl Peptidase II
- (2014) M. Schnurr et al. JOURNAL OF IMMUNOLOGY
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- Adjuvants and myeloid-derived suppressor cells: Enemies or allies in therapeutic cancer vaccination
- (2014) Audry Fernández et al. Human Vaccines & Immunotherapeutics
- Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors
- (2014) By Zhao et al. Journal for ImmunoTherapy of Cancer
- Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy
- (2013) Joseph G. Crompton et al. IMMUNOLOGICAL REVIEWS
- Immune system targeting by biodegradable nanoparticles for cancer vaccines
- (2013) Joana M. Silva et al. JOURNAL OF CONTROLLED RELEASE
- Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
- (2013) Satoshi Wada et al. Journal of Translational Medicine
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD4+ T Cells Play a Critical Role in the Generation of Primary and Memory Antitumor Immune Responses Elicited by SA-4-1BBL and TAA-Based Vaccines in Mouse Tumor Models
- (2013) Rajesh K. Sharma et al. PLoS One
- Co-stimulatory tumor necrosis factor ligands as adjuvants for the development of subunit-based anticancer vaccines
- (2013) Haval Shirwan et al. OncoImmunology
- Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors
- (2013) Willem W Overwijk et al. Journal for ImmunoTherapy of Cancer
- PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer
- (2012) C. Badoual et al. CANCER RESEARCH
- MF59 formulated with CpG ODN as a potent adjuvant of recombinant HSP65-MUC1 for inducing anti-MUC1+ tumor immunity in mice
- (2012) Ming Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4+ T Cells into CD4+FoxP3+ T Regulatory Cells by Production of IFN-γ
- (2012) Shravan Madireddi et al. PLoS One
- Prime-Boost Vaccination with SA-4-1BBL Costimulatory Molecule and Survivin Eradicates Lung Carcinoma in CD8+ T and NK Cell Dependent Manner
- (2012) Abhishek K. Srivastava et al. PLoS One
- Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix™ in mice
- (2012) Ji Eun Han et al. VACCINE
- Cross-priming for antitumor CTL induced by soluble Ag + polyI:C depends on the TICAM-1 pathway in mouse CD11c+/CD8α+dendritic cells
- (2012) Masahiro Azuma et al. OncoImmunology
- CTLA-4 blockade increases antigen-specific CD8+ T cells in prevaccinated patients with melanoma: three cases
- (2011) Jianda Yuan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Bacterial ghosts as carriers of protein subunit and DNA-encoded antigens for vaccine applications
- (2011) Abbas Muhammad et al. Expert Review of Vaccines
- ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway
- (2011) Nicholas S Wilson et al. IMMUNOLOGY AND CELL BIOLOGY
- Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
- (2011) Paolo A Ascierto et al. Journal of Translational Medicine
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
- (2011) Douglas J. Schwartzentruber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells
- (2011) M. K. L. MacLeod et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 4-1BB Ligand as an Effective Multifunctional Immunomodulator and Antigen Delivery Vehicle for the Development of Therapeutic Cancer Vaccines
- (2010) R. K. Sharma et al. CANCER RESEARCH
- Unique Th1/Th2 Phenotypes Induced during Priming and Memory Phases by Use of Interleukin-12 (IL-12) or IL-28B Vaccine Adjuvants in Rhesus Macaques
- (2010) M. P. Morrow et al. Clinical and Vaccine Immunology
- Induction of T cell anergy: integration of environmental cues and infectious tolerance
- (2010) Pascal Chappert et al. CURRENT OPINION IN IMMUNOLOGY
- Inflammatory cytokines as a third signal for T cell activation
- (2010) Julie M Curtsinger et al. CURRENT OPINION IN IMMUNOLOGY
- ISCOMATRIX™ vaccines: Safety in human clinical studies
- (2010) Andrew McKenzie et al. Human vaccines & immunotherapeutics
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Lympho-geographical concepts in vaccine delivery
- (2010) Pål Johansen et al. JOURNAL OF CONTROLLED RELEASE
- Versatile Virus-Like Particle Carrier for Epitope Based Vaccines
- (2010) Alain C. Tissot et al. PLoS One
- Adjuvants for cancer vaccines
- (2010) Thomas W. Dubensky et al. SEMINARS IN IMMUNOLOGY
- Costimulation as a Platform for the Development of Vaccines: A Peptide-Based Vaccine Containing a Novel Form of 4-1BB Ligand Eradicates Established Tumors
- (2009) R. K. Sharma et al. CANCER RESEARCH
- ProtEx™ technology for the generation of novel therapeutic cancer vaccines
- (2009) Rich-Henry Schabowsky et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Tumor-mediated inhibition of dendritic cell differentiation is mediated by down regulation of protein kinase C beta II expression
- (2009) Matthew R. Farren et al. IMMUNOLOGIC RESEARCH
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- CL097, A TLR7/8 LIGAND, INHIBITS TLR-4-DEPENDENT ACTIVATION OF IRAK-M AND BCL-3 EXPRESSION
- (2009) Branka Petricevic et al. SHOCK
- The capacity of the TNF family members 4-1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells
- (2008) Johanna Kober et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Heat shock protein derivatives for delivery of antigens to antigen presenting cells
- (2007) Makiya Nishikawa et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started